Teppei Kamimura

Teppei Kamimura

Auto-generated profile, based on publicly available information

Teppei Kamimura

Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Stroke
Verified
Journal Article
Closed access
PDF file
TKTeppei Kamimura
Teppei Kamimura
SOShuhei Okazaki
Shuhei Okazaki
TMTakaaki Morimoto
Takaaki Morimoto
HKHatasu Kobayashi
Hatasu Kobayashi
KHKouji Harada
Kouji Harada
MIMasafumi Ihara
Masafumi Ihara
Background and Purpose—: The ring finger protein 213 gene ( RNF213 ) is a susceptibility gene for moyamoya disease and large-artery ischemic stroke in East Asia. We examined the prevalence and correlates of the RNF213 p.R4810K variant in patients with early-onset ischemic stroke in a Japanese single-center cohort. Methods—: We analyzed 70 early-onset stroke patients with intracranial arterial stenosis who developed a noncardioembolic stroke or transient ischemic attack from 20 to 60 years of age. Patients with moyamoya disease were excluded. Results—: The RNF213 p.R4810K variant was found in 17 patients (24%), and more often in women than men (38% versus 16%, odds ratio 3.3; 95% CI, 1.1–10.2, P =0.04). The variant was identified in 35% of patients with stenosis in the M1 segment of the middle cerebral artery or the A1 segment of the anterior cerebral artery (odds ratio, 25.0; 95% CI, 1.4–438; P <0.01) but in only one patient (9%) with intracranial posterior circulation stenosis. Conventional atherosclerotic risk factors did not differ between variant carriers and noncarriers. Conclusions—: The RNF213 p.R4810K variant is common in early-onset ischemic stroke with anterior circulation stenosis in Japan. Further investigation of the RNF213 gene will provide new insights into pathogenetic mechanisms of early-onset stroke.

2 October 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MNMasahiro Nakamori
Masahiro Nakamori
NHNaohisa Hosomi
Naohisa Hosomi
KTKeisuke Tachiyama
Keisuke Tachiyama
TKTeppei Kamimura
Teppei Kamimura
HMHayato Matsushima
Hayato Matsushima
HMHirofumi Maruyama
Hirofumi Maruyama
Associations between cognitive decline and cerebral microbleeds (CMBs) have received increasing attention. An association between CMB distribution (deep or lobar) and cognitive decline has been reported, but these findings are controversial. We investigated the association between magnetic resonance imaging (MRI) findings, including CMBs, and cognitive function in patients with first-ever lacunar infarction. We retrospectively included consecutive patients admitted with first-ever lacunar infarction identified by MRI from July 1, 2011, to December 31, 2018. We excluded patients diagnosed with dementia, including strategic single-infarct dementia, before or after the onset of stroke. The Mini-Mental State Examination (MMSE) was performed within 3 days of admission. We searched the records of 273 patients (age 72.0 ± 11.2 years, 95 females). The median MMSE score was 27 (interquartile range 25.5–29). In a univariate analysis, the MMSE score was associated with age, body mass index (BMI), education, dyslipidemia, chronic kidney disease (CKD), periventricular hyperintensity, medial temporal atrophy, lobar CMBs, and mixed CMBs (p < 0.20). The lacunar infarction location was not associated with the MMSE score. In a multivariate analysis of these factors, lobar CMBs (p < 0.001) and mixed CMBs (p = 0.008) were independently associated with the MMSE score. Lobar CMBs were associated with cognitive impairment.

5 February 2019 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
KTKeisuke Tokunaga
Keisuke Tokunaga
MKMasatoshi Koga
Masatoshi Koga
RIRyo Itabashi
Ryo Itabashi
HYHiroshi Yamagami
Hiroshi Yamagami
KTKenichi Todo
Kenichi Todo
KMKazuo Minematsu
Kazuo Minematsu
Background: We aimed to clarify associations between prior anticoagulation and short‐ or long‐term clinical outcomes in ischemic stroke or transient ischemic attack patients with nonvalvular atrial fibrillation. Methods and Results: A total of 1189 ischemic stroke or transient ischemic attack patients with nonvalvular atrial fibrillation who were hospitalized within 7 days after onset were analyzed. Of these, 813 patients (68.4%) received no prior anticoagulation, 310 (26.1%) received prior warfarin treatment with an international normalized ratio ( INR ) <2 on admission, 28 (2.4%) received prior warfarin treatment with an INR ≥2 on admission, and the remaining 38 (3.2%) received prior direct oral anticoagulant treatment. Prior warfarin treatment was associated with a lower risk of death or disability at 3 months compared with no prior anticoagulation ( INR <2: adjusted odds ratio: 0.58; 95% CI, 0.42–0.81; P =0.001; INR ≥2: adjusted odds ratio: 0.40; 95% CI, 0.16–0.97; P =0.043) but was not associated with a lower risk of death or disability at 2 years. Prior warfarin treatment with an INR ≥2 on admission was associated with a higher risk of ischemic events within 2 years compared with no prior anticoagulation (adjusted hazard ratio: 2.94; 95% CI, 1.20–6.15; P =0.021). Conclusions: Prior warfarin treatment was associated with a lower risk of death or disability at 3 months but was not associated with a lower risk of death or disability at 2 years in ischemic stroke or transient ischemic attack patients with nonvalvular atrial fibrillation. Prior warfarin treatment with an INR ≥2 on admission was associated with a higher risk of ischemic events within 2 years. Clinical Trial Registration: URL : http://www.clinicaltrials.gov . Unique identifier: NCT 01581502.

14 January 2023 in European Geriatric Medicine
Verified
Journal Article
Closed access
PDF file
TKTeppei Kamimura
Teppei Kamimura
MNMasahiro Nakamori
Masahiro Nakamori
HNHiroyuki Naito
Hiroyuki Naito
SAShiro Aoki
Shiro Aoki
TNTomohisa Nezu
Tomohisa Nezu
NHNaohisa Hosomi
Naohisa Hosomi

1 May 2022 in Journal of Atherosclerosis and Thrombosis
Verified
Journal Article
Open access
PDF file
HNHiroyuki Naito
Hiroyuki Naito
TNTomohisa Nezu
Tomohisa Nezu
NHNaohisa Hosomi
Naohisa Hosomi
DKDaisuke Kuzume
Daisuke Kuzume
SAShiro Aoki
Shiro Aoki
HMHirofumi Maruyama
Hirofumi Maruyama
Aims: Elevated serum alkaline phosphatase (ALP) levels are associated with an increased risk of cerebrocardiovascular diseases. However, the associations of ALP with peripheral arterial disease (PAD) and outcomes in patients with acute ischemic stroke (AIS) are not well-known. Methods: We examined the association between ALP levels and the ankle–brachial index (ABI) in 2111 consecutive patients with AIS. A poor functional outcome was defined as a modified Rankin Scale (mRS) score of 3–6 at 3 months after stroke. A low ABI was defined as a value of ≤ 0.9. Results: Of the total cohort, 482 patients (22.8%) had a low ABI. ALP levels were higher in patients with a low ABI than in those without (p<0.001). The multivariable logistic analysis revealed that quartiles of ALP levels were significantly associated with a low ABI (odds ratio [OR]: 1.20, 95% confidence interval [CI]: 1.08–1.33). Of the 1322 patients with a premorbid mRS score of 0–2, 434 patients (32.8%) had a poor outcome. The multivariable analysis revealed that elevated serum ALP levels and a low ABI were independently associated with poor stroke outcomes after adjustment for baseline characteristics (OR: 1.21, 95% CI: 1.07–1.38, and OR: 2.00, 95% CI: 1.40–2.84, respectively). Conclusions: Increased serum ALP levels are significantly associated with a low ABI. These indicators are independent prognostic factors for poor stroke outcomes at 3 months.

1 August 2020 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
TKTeppei Kamimura
Teppei Kamimura
TNTomohisa Nezu
Tomohisa Nezu
SAShiro Aoki
Shiro Aoki
HUHiroki Ueno
Hiroki Ueno
NHNaohisa Hosomi
Naohisa Hosomi
HMHirofumi Maruyama
Hirofumi Maruyama